The Claim
Functionalized peptides with a photooxygenation catalyst at position 16 selectively and irreversibly inactivate myostatin upon near-infrared light irradiation, leading to suppression of a key regulator of muscle growth in muscle atrophic disorders.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A specially designed peptide that activates under near-infrared light permanently disables myostatin, a protein that limits muscle growth, thereby reducing muscle atrophy.
See the scientific wording
Functionalized peptides with a photooxygenation catalyst at position 16 can selectively and irreversibly inactivate myostatin upon near-infrared light irradiation, offering a potential strategy for treating muscle atrophic disorders by catalytically suppressing a key regulator of muscle growth.
A specially designed peptide binds to myostatin, and when near-infrared light hits it, the peptide produces reactive oxygen that permanently damages myostatin, stopping it from blocking muscle growth.
What the research says
1 studyScientists made a special protein piece that, when hit with a safe kind of light, permanently turns off a body protein that stops muscles from growing. This could help people with muscle-wasting diseases.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.